Title:
【発明の名称】CD8+細胞の個数を減少させるイプリフラボンの使用
Document Type and Number:
Japanese Patent JP2001503371
Kind Code:
A
Abstract:
The present invention relates to pharmaceutical composition suitable to decrease the number of CD8+ cells comprising as active ingredient 7-isopropoxyisoflavone in admixture with suitable inert, solid or liquid carriers and optionally with usual therapeutic additives and auxiliary agents. The pharmaceutical compositions according to the invention are prepared by known methods and are suitable for the treatment of human or animal subjects being in a condition where selective suppression of CD8+ lymphocytes is desirable.
Inventors:
Bé Covertille, Atteira
Allani, Peter
Kerepeshi, Theresia
Barley, Jiuljii
Tal, Atteira
Allani, Peter
Kerepeshi, Theresia
Barley, Jiuljii
Tal, Atteira
Application Number:
JP50646497A
Publication Date:
March 13, 2001
Filing Date:
July 16, 1996
Export Citation:
Assignee:
Quinoine, jiocell, essille, vegetation, thermekek, zyara, el, te
International Classes:
A61K31/352; A61P37/02; (IPC1-7): A61K31/352; A61P37/02
Attorney, Agent or Firm:
Yoshio Kawaguchi (1 person outside)
Previous Patent: 眼の神経損傷の処置に（２−イミダゾリン−２−イルアミノ）キノキサリ...
Next Patent: 非ステロイド系抗炎症剤のゼラチンカプセルへの配合を目的とした安定な...
Next Patent: 非ステロイド系抗炎症剤のゼラチンカプセルへの配合を目的とした安定な...